XML 35 R16.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity
 12 Months Ended
Dec. 27, 2024
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ Equity
At December 27, 2024, the Company had 22,549 authorized, but unissued, cumulative preferred shares, $100 par value. The Company also has authorized, but not issued, a separate class of 3 million shares of preferred stock, $1 par value.

Changes in components of accumulated other comprehensive income (loss), net of tax were (in thousands):
Pension and
Postretirement
Medical		Cumulative
Translation
Adjustment		Total
Balance, December 31, 2021$(60,107)$(20,062)$(80,169)
Other comprehensive income (loss) before reclassifications16,083 (9,582)6,501 
Amounts reclassified from accumulated other comprehensive income4,290 — 4,290 
Balance, December 30, 2022(39,734)(29,644)(69,378)
Other comprehensive income (loss) before reclassifications(28,162)25,661 (2,501)
Amounts reclassified from accumulated other comprehensive income36,884 — 36,884 
Balance, December 29, 2023(31,012)(3,983)(34,995)
Other comprehensive income (loss) before reclassifications15,098 (32,446)(17,348)
Amounts reclassified from accumulated other comprehensive income2,769 — 2,769 
Balance, December 27, 2024$(13,145)$(36,429)$(49,574)
Amounts related to pension and postretirement medical adjustments are classified to non-service components of pension cost that are included within other non-operating expenses. Included in the 2023 reclassifications were $42 million of pension settlement losses. See Note J for additional details regarding pension and postretirement medical plans.